Research Projects & Grants

College/University

  • Intrathecal 2-Hydroxypropyl-ß-cyclodextrin for neurological decline in patients with Niemann-Pick disease type C1, Role: PI, Rush University Medical Center, (12/2024 - 12/2025) Status: Approved

For Profit Organization

  • Cerebral Palsy Risk Identification System (CPRIS), Role: PD/PI, NeuroComp Systems, Inc., (08/2019 - 07/2020) Status: Closed

Other Research

  • REACH:  Randomised Trial of Rehabilitation Very Early in Congenital Hemiplegia Site Principal Investigator (01/2019 - 05/2020)
  • Pharmacokinetics of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine) (BATTM) in Pediatric Patients with a Confirmed or Suspected Exposure to Botulinum Toxin Sub-investigator (05/2017 - 12/2017)